Antispasmodics Drug Market - Global Outlook and Forecast 2022-2028

January 2022 | 63 pages | ID: ADB83521BCC7EN
Market Monitor Global

Abstracts

It is a drug that suppresses muscle spasms, a type of antispasmodic used for smooth muscle contraction, especially in the tubular organs of the gastrointestinal tract.

This report contains market size and forecasts of Antispasmodics Drug in Global, including the following market information:

Global Antispasmodics Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Antispasmodics Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Dicyclomine Hydrochloride Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Antispasmodics Drug include Allergan, Hikma Pharmaceutical, Lannett, Mylan, Nexus Pharmaceuticals, Akorn, Aurobindo Pharma, Daiichi Sankyo and Fresenius Kabi, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Antispasmodics Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Antispasmodics Drug Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Antispasmodics Drug Market Segment Percentages, by Type, 2021 (%)

• Dicyclomine Hydrochloride
• Loperamide Hydrochloride
• Others

Global Antispasmodics Drug Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Antispasmodics Drug Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Homecare
• Specialty Clinic
• Others

Global Antispasmodics Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Antispasmodics Drug Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Antispasmodics Drug revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Antispasmodics Drug revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Allergan
• Hikma Pharmaceutical
• Lannett
• Mylan
• Nexus Pharmaceuticals
• Akorn
• Aurobindo Pharma
• Daiichi Sankyo
• Fresenius Kabi
• Shanghai Fosun Pharmaceutical?Group?
• SunGen Pharma

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Antispasmodics Drug Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Antispasmodics Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ANTISPASMODICS DRUG OVERALL MARKET SIZE

2.1 Global Antispasmodics Drug Market Size: 2021 VS 2028
2.2 Global Antispasmodics Drug Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Antispasmodics Drug Players in Global Market
3.2 Top Global Antispasmodics Drug Companies Ranked by Revenue
3.3 Global Antispasmodics Drug Revenue by Companies
3.4 Top 3 and Top 5 Antispasmodics Drug Companies in Global Market, by Revenue in 2021
3.5 Global Companies Antispasmodics Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Antispasmodics Drug Players in Global Market
  3.6.1 List of Global Tier 1 Antispasmodics Drug Companies
  3.6.2 List of Global Tier 2 and Tier 3 Antispasmodics Drug Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Antispasmodics Drug Market Size Markets, 2021 & 2028
  4.1.2 Dicyclomine Hydrochloride
  4.1.3 Loperamide Hydrochloride
  4.1.4 Others
4.2 By Type - Global Antispasmodics Drug Revenue & Forecasts
  4.2.1 By Type - Global Antispasmodics Drug Revenue, 2017-2022
  4.2.2 By Type - Global Antispasmodics Drug Revenue, 2023-2028
  4.2.3 By Type - Global Antispasmodics Drug Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Antispasmodics Drug Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Homecare
  5.1.4 Specialty Clinic
  5.1.5 Others
5.2 By Application - Global Antispasmodics Drug Revenue & Forecasts
  5.2.1 By Application - Global Antispasmodics Drug Revenue, 2017-2022
  5.2.2 By Application - Global Antispasmodics Drug Revenue, 2023-2028
  5.2.3 By Application - Global Antispasmodics Drug Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Antispasmodics Drug Market Size, 2021 & 2028
6.2 By Region - Global Antispasmodics Drug Revenue & Forecasts
  6.2.1 By Region - Global Antispasmodics Drug Revenue, 2017-2022
  6.2.2 By Region - Global Antispasmodics Drug Revenue, 2023-2028
  6.2.3 By Region - Global Antispasmodics Drug Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Antispasmodics Drug Revenue, 2017-2028
  6.3.2 US Antispasmodics Drug Market Size, 2017-2028
  6.3.3 Canada Antispasmodics Drug Market Size, 2017-2028
  6.3.4 Mexico Antispasmodics Drug Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Antispasmodics Drug Revenue, 2017-2028
  6.4.2 Germany Antispasmodics Drug Market Size, 2017-2028
  6.4.3 France Antispasmodics Drug Market Size, 2017-2028
  6.4.4 U.K. Antispasmodics Drug Market Size, 2017-2028
  6.4.5 Italy Antispasmodics Drug Market Size, 2017-2028
  6.4.6 Russia Antispasmodics Drug Market Size, 2017-2028
  6.4.7 Nordic Countries Antispasmodics Drug Market Size, 2017-2028
  6.4.8 Benelux Antispasmodics Drug Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Antispasmodics Drug Revenue, 2017-2028
  6.5.2 China Antispasmodics Drug Market Size, 2017-2028
  6.5.3 Japan Antispasmodics Drug Market Size, 2017-2028
  6.5.4 South Korea Antispasmodics Drug Market Size, 2017-2028
  6.5.5 Southeast Asia Antispasmodics Drug Market Size, 2017-2028
  6.5.6 India Antispasmodics Drug Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Antispasmodics Drug Revenue, 2017-2028
  6.6.2 Brazil Antispasmodics Drug Market Size, 2017-2028
  6.6.3 Argentina Antispasmodics Drug Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Antispasmodics Drug Revenue, 2017-2028
  6.7.2 Turkey Antispasmodics Drug Market Size, 2017-2028
  6.7.3 Israel Antispasmodics Drug Market Size, 2017-2028
  6.7.4 Saudi Arabia Antispasmodics Drug Market Size, 2017-2028
  6.7.5 UAE Antispasmodics Drug Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Allergan
  7.1.1 Allergan Corporate Summary
  7.1.2 Allergan Business Overview
  7.1.3 Allergan Antispasmodics Drug Major Product Offerings
  7.1.4 Allergan Antispasmodics Drug Revenue in Global Market (2017-2022)
  7.1.5 Allergan Key News
7.2 Hikma Pharmaceutical
  7.2.1 Hikma Pharmaceutical Corporate Summary
  7.2.2 Hikma Pharmaceutical Business Overview
  7.2.3 Hikma Pharmaceutical Antispasmodics Drug Major Product Offerings
  7.2.4 Hikma Pharmaceutical Antispasmodics Drug Revenue in Global Market (2017-2022)
  7.2.5 Hikma Pharmaceutical Key News
7.3 Lannett
  7.3.1 Lannett Corporate Summary
  7.3.2 Lannett Business Overview
  7.3.3 Lannett Antispasmodics Drug Major Product Offerings
  7.3.4 Lannett Antispasmodics Drug Revenue in Global Market (2017-2022)
  7.3.5 Lannett Key News
7.4 Mylan
  7.4.1 Mylan Corporate Summary
  7.4.2 Mylan Business Overview
  7.4.3 Mylan Antispasmodics Drug Major Product Offerings
  7.4.4 Mylan Antispasmodics Drug Revenue in Global Market (2017-2022)
  7.4.5 Mylan Key News
7.5 Nexus Pharmaceuticals
  7.5.1 Nexus Pharmaceuticals Corporate Summary
  7.5.2 Nexus Pharmaceuticals Business Overview
  7.5.3 Nexus Pharmaceuticals Antispasmodics Drug Major Product Offerings
  7.5.4 Nexus Pharmaceuticals Antispasmodics Drug Revenue in Global Market (2017-2022)
  7.5.5 Nexus Pharmaceuticals Key News
7.6 Akorn
  7.6.1 Akorn Corporate Summary
  7.6.2 Akorn Business Overview
  7.6.3 Akorn Antispasmodics Drug Major Product Offerings
  7.6.4 Akorn Antispasmodics Drug Revenue in Global Market (2017-2022)
  7.6.5 Akorn Key News
7.7 Aurobindo Pharma
  7.7.1 Aurobindo Pharma Corporate Summary
  7.7.2 Aurobindo Pharma Business Overview
  7.7.3 Aurobindo Pharma Antispasmodics Drug Major Product Offerings
  7.7.4 Aurobindo Pharma Antispasmodics Drug Revenue in Global Market (2017-2022)
  7.7.5 Aurobindo Pharma Key News
7.8 Daiichi Sankyo
  7.8.1 Daiichi Sankyo Corporate Summary
  7.8.2 Daiichi Sankyo Business Overview
  7.8.3 Daiichi Sankyo Antispasmodics Drug Major Product Offerings
  7.8.4 Daiichi Sankyo Antispasmodics Drug Revenue in Global Market (2017-2022)
  7.8.5 Daiichi Sankyo Key News
7.9 Fresenius Kabi
  7.9.1 Fresenius Kabi Corporate Summary
  7.9.2 Fresenius Kabi Business Overview
  7.9.3 Fresenius Kabi Antispasmodics Drug Major Product Offerings
  7.9.4 Fresenius Kabi Antispasmodics Drug Revenue in Global Market (2017-2022)
  7.9.5 Fresenius Kabi Key News
7.10 Shanghai Fosun Pharmaceutical?Group?
  7.10.1 Shanghai Fosun Pharmaceutical?Group? Corporate Summary
  7.10.2 Shanghai Fosun Pharmaceutical?Group? Business Overview
  7.10.3 Shanghai Fosun Pharmaceutical?Group? Antispasmodics Drug Major Product Offerings
  7.10.4 Shanghai Fosun Pharmaceutical?Group? Antispasmodics Drug Revenue in Global Market (2017-2022)
  7.10.5 Shanghai Fosun Pharmaceutical?Group? Key News
7.11 SunGen Pharma
  7.11.1 SunGen Pharma Corporate Summary
  7.11.2 SunGen Pharma Business Overview
  7.11.3 SunGen Pharma Antispasmodics Drug Major Product Offerings
  7.11.4 SunGen Pharma Antispasmodics Drug Revenue in Global Market (2017-2022)
  7.11.5 SunGen Pharma Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Antispasmodics Drug Market Opportunities & Trends in Global Market
Table 2. Antispasmodics Drug Market Drivers in Global Market
Table 3. Antispasmodics Drug Market Restraints in Global Market
Table 4. Key Players of Antispasmodics Drug in Global Market
Table 5. Top Antispasmodics Drug Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Antispasmodics Drug Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Antispasmodics Drug Revenue Share by Companies, 2017-2022
Table 8. Global Companies Antispasmodics Drug Product Type
Table 9. List of Global Tier 1 Antispasmodics Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Antispasmodics Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Antispasmodics Drug Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Antispasmodics Drug Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Antispasmodics Drug Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Antispasmodics Drug Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Antispasmodics Drug Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Antispasmodics Drug Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Antispasmodics Drug Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Antispasmodics Drug Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Antispasmodics Drug Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Antispasmodics Drug Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Antispasmodics Drug Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Antispasmodics Drug Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Antispasmodics Drug Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Antispasmodics Drug Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Antispasmodics Drug Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Antispasmodics Drug Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Antispasmodics Drug Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Antispasmodics Drug Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Antispasmodics Drug Revenue, (US$, Mn), 2023-2028
Table 30. Allergan Corporate Summary
Table 31. Allergan Antispasmodics Drug Product Offerings
Table 32. Allergan Antispasmodics Drug Revenue (US$, Mn), (2017-2022)
Table 33. Hikma Pharmaceutical Corporate Summary
Table 34. Hikma Pharmaceutical Antispasmodics Drug Product Offerings
Table 35. Hikma Pharmaceutical Antispasmodics Drug Revenue (US$, Mn), (2017-2022)
Table 36. Lannett Corporate Summary
Table 37. Lannett Antispasmodics Drug Product Offerings
Table 38. Lannett Antispasmodics Drug Revenue (US$, Mn), (2017-2022)
Table 39. Mylan Corporate Summary
Table 40. Mylan Antispasmodics Drug Product Offerings
Table 41. Mylan Antispasmodics Drug Revenue (US$, Mn), (2017-2022)
Table 42. Nexus Pharmaceuticals Corporate Summary
Table 43. Nexus Pharmaceuticals Antispasmodics Drug Product Offerings
Table 44. Nexus Pharmaceuticals Antispasmodics Drug Revenue (US$, Mn), (2017-2022)
Table 45. Akorn Corporate Summary
Table 46. Akorn Antispasmodics Drug Product Offerings
Table 47. Akorn Antispasmodics Drug Revenue (US$, Mn), (2017-2022)
Table 48. Aurobindo Pharma Corporate Summary
Table 49. Aurobindo Pharma Antispasmodics Drug Product Offerings
Table 50. Aurobindo Pharma Antispasmodics Drug Revenue (US$, Mn), (2017-2022)
Table 51. Daiichi Sankyo Corporate Summary
Table 52. Daiichi Sankyo Antispasmodics Drug Product Offerings
Table 53. Daiichi Sankyo Antispasmodics Drug Revenue (US$, Mn), (2017-2022)
Table 54. Fresenius Kabi Corporate Summary
Table 55. Fresenius Kabi Antispasmodics Drug Product Offerings
Table 56. Fresenius Kabi Antispasmodics Drug Revenue (US$, Mn), (2017-2022)
Table 57. Shanghai Fosun Pharmaceutical(Group) Corporate Summary
Table 58. Shanghai Fosun Pharmaceutical(Group) Antispasmodics Drug Product Offerings
Table 59. Shanghai Fosun Pharmaceutical(Group) Antispasmodics Drug Revenue (US$, Mn), (2017-2022)
Table 60. SunGen Pharma Corporate Summary
Table 61. SunGen Pharma Antispasmodics Drug Product Offerings
Table 62. SunGen Pharma Antispasmodics Drug Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Antispasmodics Drug Segment by Type in 2021
Figure 2. Antispasmodics Drug Segment by Application in 2021
Figure 3. Global Antispasmodics Drug Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Antispasmodics Drug Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Antispasmodics Drug Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Antispasmodics Drug Revenue in 2021
Figure 8. By Type - Global Antispasmodics Drug Revenue Market Share, 2017-2028
Figure 9. By Application - Global Antispasmodics Drug Revenue Market Share, 2017-2028
Figure 10. By Region - Global Antispasmodics Drug Revenue Market Share, 2017-2028
Figure 11. By Country - North America Antispasmodics Drug Revenue Market Share, 2017-2028
Figure 12. US Antispasmodics Drug Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Antispasmodics Drug Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Antispasmodics Drug Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Antispasmodics Drug Revenue Market Share, 2017-2028
Figure 16. Germany Antispasmodics Drug Revenue, (US$, Mn), 2017-2028
Figure 17. France Antispasmodics Drug Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Antispasmodics Drug Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Antispasmodics Drug Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Antispasmodics Drug Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Antispasmodics Drug Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Antispasmodics Drug Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Antispasmodics Drug Revenue Market Share, 2017-2028
Figure 24. China Antispasmodics Drug Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Antispasmodics Drug Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Antispasmodics Drug Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Antispasmodics Drug Revenue, (US$, Mn), 2017-2028
Figure 28. India Antispasmodics Drug Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Antispasmodics Drug Revenue Market Share, 2017-2028
Figure 30. Brazil Antispasmodics Drug Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Antispasmodics Drug Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Antispasmodics Drug Revenue Market Share, 2017-2028
Figure 33. Turkey Antispasmodics Drug Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Antispasmodics Drug Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Antispasmodics Drug Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Antispasmodics Drug Revenue, (US$, Mn), 2017-2028
Figure 37. Allergan Antispasmodics Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Hikma Pharmaceutical Antispasmodics Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Lannett Antispasmodics Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Mylan Antispasmodics Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Nexus Pharmaceuticals Antispasmodics Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Akorn Antispasmodics Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Aurobindo Pharma Antispasmodics Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Daiichi Sankyo Antispasmodics Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Fresenius Kabi Antispasmodics Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Shanghai Fosun Pharmaceutical(Group) Antispasmodics Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. SunGen Pharma Antispasmodics Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)